Barry Lutz


Many human diseases can be diagnosed by biochemical analysis of blood, saliva, urine, or other fluids. Our group creates new tests to diagnose disease by engineering assay chemistries and devices, with an emphasis on nucleic acid assays (DNA and RNA). We aim to make easy-to-use tests for global health settings or non-laboratory settings in high-income locations. The group is actively involved in entrepreneurship, industry collaboration, and translation for global health settings

MolES-related education interests: Global Health Technologies: Molecular Diagnostics – a bioengineering course covering the basics of amplification-based DNA & RNA detection for disease diagnosis, the underlying engineering principles, and applications in the context of global health.